CIBC Asset Management’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,139
| Closed | -$15.2K | – | 1215 |
|
|
2024
Q2 | $15.2K | Buy |
1,139
+511
| +81% | +$6.83K | ﹤0.01% | 1142 |
|
|
2024
Q1 | $29.1K | Hold |
628
| – | – | ﹤0.01% | 1116 |
|
|
2023
Q4 | $42.5K | Hold |
628
| – | – | ﹤0.01% | 1078 |
|
|
2023
Q3 | $45.5K | Hold |
628
| – | – | ﹤0.01% | 1025 |
|
|
2023
Q2 | $46.7K | Hold |
628
| – | – | ﹤0.01% | 1066 |
|
|
2023
Q1 | $33.4K | Sell |
628
-155
| -20% | -$8.25K | ﹤0.01% | 1045 |
|
|
2022
Q4 | $52.9K | Sell |
783
-1,109
| -59% | -$75K | ﹤0.01% | 1030 |
|
|
2022
Q3 | $236K | Hold |
1,892
| – | – | ﹤0.01% | 987 |
|
|
2022
Q2 | $180K | Sell |
1,892
-138
| -7% | -$13.1K | ﹤0.01% | 1143 |
|
|
2022
Q1 | $327K | Hold |
2,030
| – | – | ﹤0.01% | 1009 |
|
|
2021
Q4 | $675K | Buy |
+2,030
| New | +$675K | ﹤0.01% | 775 |
|